Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG2 cells: An in vitro model of non-alcoholic fatty liver disease

PLEIOTROPIC EFFECTS OF STATINS

Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994 · see citing works

Association of nonalcoholic fatty liver disease with insulin resistance

Marchesini, G., Brizi, M., Morselli‐Labate, A. M., Bianchi, G. P., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,564 · see citing works

The discovery and development of HMG-CoA reductase inhibitors.

Endo, A. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41379-3 · Cited by 847 · see citing works

A Human Hepatocellular in Vitro Model to Investigate Steatosis

Gómez-Lechón, M. J., Donato, M. T., Martínez-Romero, A., Jiménez, N., Castell, J. V., & O’Connor, J.-E. (2007) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.11.004 · Cited by 576 · see citing works

Effects of ethanol on lipid metabolism.

Baraona, E., & Lieber, C. S. (1979) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40613-3 · Cited by 392 · see citing works

Comparison of statins in hypertriglyceridemia

Stein, E. A., Lane, M., & Laskarzewski, P. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00041-1 · Cited by 386 · see citing works

Standardization of platelet‐derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop

Lacroix, R., Robert, S., PONCELET, P., Kasthuri, R. S., Key, N. S., & Dignat‐George, F. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04047.x · Cited by 352 · see citing works

Treatment of non-alcoholic fatty liver disease

Adams, L. A., & Angulo, P. (2006) · Postgraduate Medical Journal · doi:10.1136/pgmj.2005.042200 · Cited by 349 · see citing works

A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis

Başaranoğlu, M., Açbay, Ö., & Sonsuz, A. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80243-8 · Cited by 304 · see citing works

Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies?

Robert, S., PONCELET, P., Lacroix, R., Arnaud, L., Giraudo, L., HAUCHARD, A., Sampol, J., & Dignat‐George, F. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03200.x · Cited by 288 · see citing works

Metabolic syndrome and risk factors for non-alcoholic fatty liver disease

Souza, M. R. D. A., Diniz, M. D. F. F. M., Medeiros-Filho, J. E. M., & de Araújo, M. S. T. (2012) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032012000100015 · Cited by 215 · see citing works

Multiple Metabolic Hits Converge on CD36 as Novel Mediator of Tubular Epithelial Apoptosis in Diabetic Nephropathy

Susztak, K., Ciccone, E., McCue, P., Sharma, K., & Böttinger, E. P. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020045 · Cited by 214 · see citing works

Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia

Hyogo, H., Tazuma, S., Arihiro, K., Iwamoto, K., Nabeshima, Y., Inoue, M., Ishitobi, T., Nonaka, M., & Chayama, K. (2008) · Metabolism · doi:10.1016/j.metabol.2008.07.030 · Cited by 206 · see citing works

Ursodeoxycholic Acid and Atorvastatin in the Treatment of Nonalcoholic Steatohepatitis

Kıyıcı, M., Gülten, M., Gurel, S., Nak, S. G., Dolar, E., Savcı, G., Adım, Ş. B., Yerci, Ö., & Memik, F. (2003) · Canadian Journal of Gastroenterology · doi:10.1155/2003/857869 · Cited by 199 · see citing works

Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells.

(2010) · PubMed Central · Cited by 181 · see citing works

On the Origin of Microparticles: From “Platelet Dust” to Mediators of Intercellular Communication

Hargett, L. A., & Bauer, N. N. (2013) · Pulmonary Circulation · doi:10.4103/2045-8932.114760 · Cited by 175 · see citing works

Reduction of lipid accumulation in HepG2 Cells by luteolin is associated with activation of AMPK and Mitigation of oxidative stress

Liu, J., Ma, Y., Wang, Y., Du, Z., Shen, J., & Peng, H. (2010) · Phytotherapy Research · doi:10.1002/ptr.3305 · Cited by 167 · see citing works

Statins in the Treatment of Dyslipidemia in the Presence of Elevated Liver Aminotransferase Levels: A Therapeutic Dilemma

Calderon, R. M., Cubeddu, L. X., Goldberg, R. B., & Schiff, E. R. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0365 · Cited by 164 · see citing works

Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

Eslami, L., Merat, S., Malekzadeh, R., Nasseri‐Moghaddam, S., & Aramin, H. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008623.pub2 · Cited by 146 · see citing works

The Influence of Dietary Fat on Liver Fat Accumulation

Green, C., & Hodson, L. (2014) · Nutrients · doi:10.3390/nu6115018 · Cited by 129 · see citing works

Treatment of non-alcoholic fatty liver disease.

(2007) · PubMed Central · Cited by 118 · see citing works

Simvastatin inhibits cell growth and induces apoptosis and G0/G1 cell cycle arrest in hepatic cancer cells

Relja, B. (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000520 · Cited by 109 · see citing works

The origin of circulating CD36 in type 2 diabetes

Alkhatatbeh, M. J., Enjeti, A. K., Acharya, S., Thorne, R. F., & Lincz, L. F. (2013) · Nutrition and Diabetes · doi:10.1038/nutd.2013.1 · Cited by 73 · see citing works

Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease

Pais, R., Pascale, A., Fedchuck, L., Charlotte, F., Poynard, T., & Ratziu, V. (2010) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.gcb.2010.06.004 · Cited by 71 · see citing works

Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression

Kah, J., Wüstenberg, A., Keller, A. D., Sirma, H., Montalbano, R., Ocker, M., Volz, T., Dandri, M., Tiegs, G., & Sass, G. (2012) · Oncology Reports · doi:10.3892/or.2012.1860 · Cited by 46 · see citing works

Effect of simvastatin on Kruppel-like factor2, endothelial nitric oxide synthase and thrombomodulin expression in endothelial cells under shear stress

Rossi, J., Rouleau, L., Tardif, J., & Leask, R. L. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.05.008 · Cited by 43 · see citing works

Statins in Nonalcoholic Fatty Liver Disease and Steatohepatitis: Updated Review

Nseir, W., & Mahamid, M. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0305-5 · Cited by 38 · see citing works

The Role of Lifestyle Change in the Prevention and Treatment of NAFLD

Centis, E., Marzocchi, R., Suppini, A., Grave, R., Villanova, N., Hickman, I. J., & Marchesini, G. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319290008 · Cited by 38 · see citing works

Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals

de Keyser, C. E., Koehler, E. M., Schouten, J. N. L., Visser, L. E., Albert Hofman, D., Janssen, H. L. A., & Stricker, B. H. C. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.04.002 · Cited by 36 · see citing works

Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD

Önnerhag, K., Nilsson, P. M., & Lindgren, S. C. (2014) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.934911 · Cited by 36 · see citing works

Non-alcoholic fatty liver disease and the statins treatment.

Dima, A., Marinescu, A. G., & Dima, A. C. (2012) · PubMed · Cited by 23 · see citing works

Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch1 expression

Huang, X., Ma, J., Xu, J., SU, Q., & Zhao, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2976 · Cited by 23 · see citing works

PURLs: statins for patients with nonalcoholic fatty liver?

Egan, M., & Prasad, S. (2011) · Europe PMC (PubMed Central) · Cited by 9 · see citing works

Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis

Chen, X., Li, L., Liu, X., Luo, R., Liao, G., Li, L., Liu, J., Cheng, J., Lu, Y., & Chen, Y. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.022 · Cited by 170 · see citing works

A Mammalian Target of Rapamycin‐Perilipin 3 (mTORC1‐Plin3) Pathway is essential to Activate Lipophagy and Protects Against Hepatosteatosis

Macia, M. G., Santos‐Ledo, A., Leslie, J., Paish, H. L., Collins, A., Scott, R., Watson, A. A., Burgoyne, R. A., White, S. A., French, J., et al. (2021) · Hepatology · doi:10.1002/hep.32048 · Cited by 76 · see citing works

Protective Effects of Lactic Acid Bacteria Against TLR4 Induced Inflammatory Response in Hepatoma HepG2 Cells Through Modulation of Toll-Like Receptor Negative Regulators of Mitogen-Activated Protein Kinase and NF-κB Signaling

Kanmani, P., & Kim, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01537 · Cited by 60 · see citing works

Human-based systems: Mechanistic NASH modelling just around the corner?

Boeckmans, J., Natale, A., Buyl, K., Rogiers, V., Kock, J. D., Vanhaecke, T., & Rodrigues, R. M. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.06.029 · Cited by 53 · see citing works

Honeybee Pollen Extracts Reduce Oxidative Stress and Steatosis in Hepatic Cells

Oyarzún, J. E., Andía, M. E., Uribe, S. A., Pizarro, P. N., Núñez, G., Montenegro, G., & Bridi, R. (2020) · Molecules · doi:10.3390/molecules26010006 · Cited by 49 · see citing works

Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway

Khalifa, O., Al-Akl, N. S., Errafii‬, K., & Arredouani, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-06143-5 · Cited by 43 · see citing works

Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma

Smiriglia, A., Lorito, N., Serra, M., Perra, A., Morandi, A., & Kowalik, M. A. (2023) · iScience · doi:10.1016/j.isci.2023.108363 · Cited by 42 · see citing works

A Comparison of Primary Human Hepatocytes and Hepatoma Cell Lines to Model the Effects of Fatty Acids, Fructose and Glucose on Liver Cell Lipid Accumulation

Huggett, Z. J., Smith, A., De Vivo, N., Gomez, D., Jethwa, P., Brameld, J. M., Bennett, A., & Salter, A. M. (2022) · Nutrients · doi:10.3390/nu15010040 · Cited by 37 · see citing works

Simvastatin Reduces Hepatic Oxidative Stress and Endoplasmic Reticulum Stress in Nonalcoholic Steatohepatitis Experimental Model

Rodrigues, G., Moreira, A. J., Bona, S., Schemitt, E. G., Marroni, C. A., Naso, F. C. D., Dias, A. S., Pires, T. R., Picada, J. N., & Marroni, N. P. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3201873 · Cited by 28 · see citing works

Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists

Pοlyzos, S. A., Bugianesi, E., Kountouras, J., & Mantzoros, C. S. (2016) · Metabolism · doi:10.1016/j.metabol.2016.08.001 · Cited by 27 · see citing works

Protective role of magnesium isoglycyrrhizinate in non-alcoholic fatty liver disease and the associated molecular mechanisms

XU, Q., Wang, J., Chen, F., Lin, K., Zhu, M., CHEN, L., Zhou, X., Li, C., & Zhu, H. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2603 · Cited by 24 · see citing works

Simvastatin protects against acetaminophen-induced liver injury in mice

Liang, H., Feng, Y., Cui, R., Qiu, M., Zhang, J., & Liu, C. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.12.076 · Cited by 24 · see citing works

A study on the treatment effects of Crataegus pinnatifida polysaccharide on non-alcoholic fatty liver in mice by modulating gut microbiota

Hao, P., Yang, X., Yin, W., Wang, X., Ling, Y., Zhu, M., Yu, Y., Chen, S., Yuan, Y., Quan, X., et al. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1383801 · Cited by 23 · see citing works

Oleic acid-induced steatosis model establishment in LMH cells and its effect on lipid metabolism

Song, H., Yang, R., Zhang, J., Sun, P., Xing, X., Wang, L., Sairijima, T., Hu, Y., Liu, Y., Cheng, H., et al. (2023) · Poultry Science · doi:10.1016/j.psj.2022.102297 · Cited by 19 · see citing works

Effect of hepatic steatosis on the progression of chronic hepatitis B: A prospective cohort and in vitro study

Chen, Y., Fan, C., Chen, Y., Liu, H., Wang, S., Ding, H., Li, L., & Ding, H. (2017) · Oncotarget · doi:10.18632/oncotarget.17380 · Cited by 19 · see citing works

Comparative Transcriptome Analysis Reveals That Exendin-4 Improves Steatosis in HepG2 Cells by Modulating Signaling Pathways Related to Lipid Metabolism

Errafii, K., Khalifa, O., Al-Akl, N. S., & Arredouani, A. (2022) · Biomedicines · doi:10.3390/biomedicines10051020 · Cited by 17 · see citing works

Targeted Delivery of Celastrol via Chondroitin Sulfate Derived Hybrid Micelles for Alleviating Symptoms in Nonalcoholic Fatty Liver Disease

Pan, Y., Zhang, Y., Ouyang, H., Gong, T., Zhang, Z., Cao, X., & Fu, Y. S. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00612 · Cited by 15 · see citing works

Octyl gallate induces hepatic steatosis in HepG2 cells through the regulation of SREBP-1c and PPAR-γ gene expression

Lima, K. G., Levorse, V. G. S., Garcia, M. C. R., Basso, B. D. S., Costa, B. P., Antunes, G. L., Luft, C., Haute, G. V., Xavier, L. L., Donadio, M. V. F., et al. (2020) · EXCLI journal · doi:10.17179/excli2020-2214 · Cited by 13 · see citing works

Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4

Errafii‬, K., Al-Akl, N. S., Khalifa, O., & Arredouani, A. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02885-4 · Cited by 12 · see citing works

Citrus depressa Hayata peel ameliorates nonalcoholic fatty liver and modulates the activity of hepatic drug-metabolizing enzymes and transporters in rats fed a high-fat diet

Li, M., Huang, C., Chen, S.-H., Lee, C.-N., & Yao, H. (2022) · Food & Function · doi:10.1039/d1fo03597e · Cited by 12 · see citing works

Investigation of the Effect of Exendin-4 on Oleic Acid-Induced Steatosis in HepG2 Cells Using Fourier Transform Infrared Spectroscopy

Khalifa, O., Mroué, K. H., Mall, R., Ullah, E., Al-Akl, N. S., & Arredouani, A. (2022) · Biomedicines · doi:10.3390/biomedicines10102652 · Cited by 11 · see citing works

Unlocking the therapeutic potential of canagliflozin in NAFLD: Insights into AMPK/SIRT1-mediated lipophagy

El‐Ashmawy, N. E., Al‐Ashmawy, G. M., Kamel, A. A., & Khedr, E. G. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167666 · Cited by 9 · see citing works

Gut microbial extracellular vesicles modulate the development of metabolic dysfunction-associated steatohepatitis through the gut-liver axis

Kwak, M., Park, B., Choi, H., Hong, W., Mun, D., Son, S.-H., Choi, Y.-S., Pathiraja, D., Eor, J. Y., Ryu, S., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108184 · Cited by 8 · see citing works

The role of probiotics in the treatment of non-alcoholic fatty liver disease (NAFLD): New insights based on meta-analysis and subgroup analysis

Xiao, R., Cao, Y., Wang, L., Tian, P., Zhai, Q., Zhao, J., Wang, G., & Zhu, Y. M. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105454 · Cited by 7 · see citing works

Targeted MicroRNA Profiling Reveals That Exendin-4 Modulates the Expression of Several MicroRNAs to Reduce Steatosis in HepG2 Cells

Khalifa, O., Ouararhni, K., Errafii‬, K., Alajez, N. M., & Arredouani, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411606 · Cited by 7 · see citing works

C-Glycosidic flavone-rich Passiflora incarnata L. leaf extracts decrease body weight and fatty liver in obese mice

Park, S., Jeong, H. Y., Choi, P. G., Kim, M. J., Seo, H., Hahm, J., Ahn, J., & Jung, C. H. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.103028 · Cited by 7 · see citing works

Synergistic action of non-digestible xylooligosaccharide and Lactiplantibacillus plantarum ZDY2013 against high fat diet and streptozocin-induced type 2 diabetes mellitus in rats

Zhan, Y., Zhang, N., Wang, K., Li, J., Jin, M., Shah, N. P., Wei, H., & Zhang, Z. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128174 · Cited by 6 · see citing works

High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats

Kaewmalee, J., Ontawong, A., Duangjai, A., Tansakul, C., Rukachaisirikul, V., Muanprasat, C., & Srimaroeng, C. (2021) · Pharmaceuticals · doi:10.3390/ph14040375 · Cited by 6 · see citing works

The HepG2 Cell Line as a Model for Studying Metabolic Dysfunction-Associated Steatotic Liver Disease

Kotlyarova, A., Iskrina, A., & Kotlyarov, S. (2026) · International journal of molecular sciences · doi:10.3390/ijms27083399 · Cited by 5 · see citing works

Exploration of the Key Genes Involved in Non-alcoholic Fatty Liver Disease and Possible MicroRNA Therapeutic Targets

Mahmoudi, A. A., Jalili, A., Butler, A. E., Aghaee‐Bakhtiari, S. H., Jamialahmadi, T., & Sahebkar, A. (2024) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2024.101365 · Cited by 5 · see citing works

Statins as a Potential Treatment for Non-alcoholic Fatty Liver Disease: Target Deconvolution using Protein-protein Interaction Network Analysis

Mahmoudi, A. A., Butler, A. E., Orekhov, A. N., Jamialahmadi, T., & Sahebkar, A. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230829164832 · Cited by 4 · see citing works

Nobiletin potentially reduce lipid accumulation by up-regulating the SIRT1-AMPK signaling pathway in HepG2 hepatocarcinoma cells

Afra, H. S., Abdolmaleki, E. Y., Jadidi, E. S. M. S., Oladi, Z., Moradi‐Sardareh, H., Nabi‐Afjadi, M., Ilbeigi, D., & Barmaki, H. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10587-z · Cited by 3 · see citing works

Exploring the Putative Involvement of MALAT1 in Mediating the Beneficial Effect of Exendin-4 on Oleic Acid-Induced Lipid Accumulation in HepG2 Cells

Khalifa, O., Ayoub, S., & Arredouani, A. (2025) · Biomedicines · doi:10.3390/biomedicines13020370 · Cited by 3 · see citing works

<em>In Vitro</em> Modeling of Fat Deposition in Metabolic Dysfunction-associated Steatotic Liver Disease

Bao, Q., Zhang, X., Chen, Y., Wang, T., & Siqin, B. (2024) · Journal of Visualized Experiments · doi:10.3791/66810 · Cited by 1 · see citing works

Bilirubin Ameliorates Oleic and Palmitic Acid Accumulation in an In Vitro Model of MASLD

Pospíšilová, K., Tulachova, N., Onhajzer, J., Dvořák, A., & Vítek, L. (2026) · Physiological Research · doi:10.33549/physiolres.935696 · Cited by 1 · see citing works

Exendin-4-induced reduction of steatosis in HepG2 cells implicates upregulation of essential lipid metabolism genes via modulation of MALAT1Preprint

Khalifa, O., Ayoub, S., & Arredouani, A. (2024) · Research Square · doi:10.21203/rs.3.rs-3996681/v1 · Cited by 1 · see citing works

A simple method of Analyzing Lipid Droplets combining Oil Red O Staining and Confocal Microscopy

Lima, K. G., Xavier, L. L., Cappellari, A. R., Morrone, F. B., Levorse, V. G. S., Filippi‐Chiela, E. C., Garcia, M. C. R., Donadio, M. V. F., Wieck, A., & de Oliveira, J. R. (2021) · Acta microscópica

Exendin-4 alleviates hepatic steatosis by lowering FABP1 and raising FOXA1 expression via the Wnt/-catenin signaling pathwayPreprint

Khalifa, O., Al-Akl, N. S., Errafii‬, K., & Arredouani, A. (2021) · Research Square · doi:10.21203/rs.3.rs-898584/v1

Application of Induced Pluripotent Stem Cells (iPSCs) in Hereditary and Viral Diseases of the Liver: Modeling and Treatment

Andriianov, V. S., Malyutina, A., Panferov, E., Karabelsky, A. V., Ivanov, R. A., Minskaia, E., & Reshetnikov, V. V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199432

Integrated Multimodal Enhanced Raman Spectroscopy (iMERS) Enables Live Single-Cell Multimolecular Profiling

Chen, S., Yu, K., & Zhu, R. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c03235

Lysine-proline-valine peptide attenuates hepatic lipid accumulation through ROS-dependent regulation of the PPARγ pathway in HepG2 cells

Lee, J.-Y., Lee, J., Jung, W., Je, J., & Lee, S. G. (2026) · Cytotechnology · doi:10.1007/s10616-026-00967-z

Metabolomics reveals mechanisms underlying enhanced Monacolin K production and lipid-lowering activity in Monascus purpureus co-fermented with Lycium barbarumPreprint

Zhai, Y., Ablimit, A., Liu, W., Dong, L., Qin, Y., Yuchi, C., Qin, Y., Huang, A., Sun, B., Liu, Y., et al. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7192739

A Strategic Formulation to Enhance the Safety and Anti-Hyperlipidaemic Activity of Simvastatin: Prototype Development

Karmakar, A., Yalamanda, V., Khairnar, Y., Nayak, S., Kumar, L., Abubakar, M., & Kumar, N. (2026) · AAPS PharmSciTech · doi:10.1208/s12249-026-03523-2

Metabolomics reveals potential mechanisms underlying enhanced Monacolin K production and lipid-lowering activity in Monascus purpureus co-fermented with Lycium barbarum

Zhai, Y., Ablimit, A., Liu, W., Dong, L., Qin, Y., Yuchi, C., Qin, Y., Huang, A., Sun, B., Liu, Y., et al. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.110241

Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG₂ cells: an in vitro model of non-alcoholic fatty liver disease

Alkhatatbeh, M. J., Lincz, L. F., & Thorne, R. F. (2016) · NOVA (University of Newcastle Australia)

Efficacy of Simvastatin in the treatment of nonalcoholic fatty liver disease and observation on changes of blood lipid

Dong-zh, P. (2013) · China Medical Herald · Cited by 1 · see citing works

Effect and Mechanism of Simvastatin on the Incidence of NAFLD in Patients with Abdominal Obesity

Huang, C. (2011) · Guide of China Medicine

Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells.

(2010) · PubMed Central · Cited by 181 · see citing works

Simvastatin Improves Microcirculatory Function in Nonalcoholic Fatty Liver Disease and Downregulates Oxidative and ALE-RAGE Stress

Pereira, E. N. G. D. S., de Araujo, B. P., Rodrigues, K. L., Silvares, R. R., Martins, C. S. M., Flores, E. E. I., Fernandes‐Santos, C., & Daliry, A. (2022) · Nutrients · doi:10.3390/nu14030716 · Cited by 43 · see citing works